“We adjusted for race”: now what? A systematic review of utilization and reporting of race in American Journal of Epidemiology and Epidemiology, 2020–2021

ME Swilley-Martinez, SA Coles, VE Miller… - Epidemiologic …, 2023 - academic.oup.com
Race is a social construct, commonly used in epidemiologic research to adjust for
confounding. However, adjustment of race may mask racial disparities thereby perpetuating …

[HTML][HTML] Enhancing interventions for prevention of mother-to-child-transmission of hepatitis B virus

PC Matthews, P Ocama, S Wang, M El-Sayed… - JHEP Reports, 2023 - Elsevier
Prevention of mother-to-child transmission of hepatitis B virus (HBV) infection is a
cornerstone of efforts to support progress towards elimination of viral hepatitis. Current …

[HTML][HTML] Effect of tenofovir disoproxil fumarate and emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: a pilot …

JJ Parienti, T Prazuck, L Peyro-Saint-Paul… - …, 2021 - thelancet.com
Background Tenofovir and emtricitabine interfere with the SARS CoV-2 ribonucleic acid
(RNA)-dependent RNA polymerase (RdRp). Several cohorts reported that people treated by …

Tenofovir disoproxil fumarate and coronavirus disease 2019 outcomes in men with HIV

G Li, LS Park, S Lodi, RW Logan, EJ Cartwright… - Aids, 2022 - journals.lww.com
Objective: To compare the risk of coronavirus disease 2019 (COVID-19) outcomes by
antiretroviral therapy (ART) regimens among men with HIV. Design: We included men with …

[HTML][HTML] Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled …

R Polo, X García-Albéniz, C Terán, M Morales… - Clinical Microbiology …, 2023 - Elsevier
Objectives To assess the effect of hydroxychloroquine (HCQ) and Tenofovir disoproxil
fumarate/emtricitabine (TDF/FTC) as pre-exposure prophylaxis on COVID-19 risk. Methods …

Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection

J Del Amo, R Polo, S Moreno, E Martínez, A Cabello… - Aids, 2022 - journals.lww.com
Background: Effective, safe, and affordable antivirals are needed for coronavirus disease
2019 (COVID-19). Several lines of research suggest that tenofovir may be effective against …

COVID‐19 pharmacotherapy utilization patterns during pregnancy: international registry of coronavirus exposure in pregnancy

WJ Westhoff, LH Smith, DF Wyszynski… - … and Drug Safety, 2022 - Wiley Online Library
Purpose Women infected with SARS‐CoV‐2 during pregnancy are at increased risk of
developing severe illness and experience a higher rate of preterm births than pregnant …

VirA+ EmiC project: Evaluating real‐world effectiveness and sustainability of integrated routine opportunistic hepatitis B and C testing in a large urban emergency …

G Nebbia, M Ruf, L Hunter… - Journal of Viral …, 2022 - Wiley Online Library
Innovative testing approaches and care pathways are required to meet global hepatitis B
virus (HBV) and hepatitis C virus (HCV) elimination goals. Routine blood‐borne virus (BBV) …

Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year's review

D Mujuni, DL Kasemire, I Ibanda, J Kabugo… - BMC Infectious …, 2022 - Springer
Background Second-line drug resistance (SLD) among tuberculosis (TB) patients is a
serious emerging challenge towards global control of the disease. We characterized SLD …

Drug repurposing and observational studies: the case of antivirals for the treatment of COVID-19

MA Hernán, J Del Amo - Annals of Internal Medicine, 2023 - acpjournals.org
Remdesivir and molnupiravir were the only 2 repurposed antivirals that were approved for
emergency use during the COVID-19 pandemic. Both drugs received their emergency use …